Nomogram model based on γ-glutamyl transferase to albumin ratio predicts survival in hepatocellular carcinoma patients with transarterial chemoembolization treatment

Figure 1 Kaplan-Meier survival curves stratified by γ-glutamyl transferase to albumin ratio. A: Overall survival of the transarterial chemoembolization alone cohort; B: The cohort after propensity score matching; C: Training set; D: Validation set; E: Dual therapy cohort; F: Triple therapy cohort. GAR: γ-glutamyl transferase to albumin ratio.

Figure 2 Nomogram constructed based on independent risk factors for predicting 1-, 2-, and 3-year overall survival in patients with hepatocellular carcinoma. GAR: γ-glutamyl transferase to albumin ratio; PVTT: Portal vein tumor thrombus.

Figure 3 Time-dependent receiver operating characteristic curves of this predictive model. AUC: Area under receiver operating characteristic curve.

Figure 4 Calibration curve of validation cohort. OS: Overall survival.

Figure 5  Decision curve analyses curve of validation cohort.